ArticleLeukemia2025
Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia.
Nikola Curik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleLeukemia2025
Nikola Curik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.